NZZ | The biodiversity of our planet, an important source of inspiration for pharmaceutical breakthroughs, is at a critical point. Its preservation will determine whether the pharmaceutical industry can continue to launch life-saving innovations in the future. Jessica Browning, Pharmaceuticals Strategist at Quantis sat down with NZZ to share insights on how the industry needs to consider biodiversity as a strategic necessity.
Latest resources
CO2 AI & Quantis release best-in-class product environmental footprinting solution for agri-food industry
Agri-food companies now have access to the most accurate solution for product environmental impact measurement and reduction.
Quantis supports FPE guidance for life cycle assessment of flexible packaging
Quantis and Flexible Packaging Europe issue new guidelines on the environmental assessment of flexible packaging.
Sustainable raw materials will drive profitability for fashion and app...
Philipp Meister, our Global Lead for Fashion & Sporting Goods and Jocelyn Wilkinson, BCG's Partner and Associate Director, jointly discuss the challenges of sustainable raw...
